Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
โ Scribed by Horsley, A. R.; Davies, J. C.; Gray, R. D.; Macleod, K. A.; Donovan, J.; Aziz, Z. A.; Bell, N. J.; Rainer, M.; Mt-Isa, S.; Voase, N.; Dewar, M. H.; Saunders, C.; Gibson, J. S.; Parra-Leiton, J.; Larsen, M. D.; Jeswiet, S.; Soussi, S.; Bakar, Y.; Meister, M. G.; Tyler, P.; Doherty, A.; Hansell, D. M.; Ashby, D.; Hyde, S. C.; Gill, D. R.; Greening, A. P.; Porteous, D. J.; Innes, J. A.; Boyd, A. C.; Griesenbach, U.; Cunningham, S.; Alton, E. W.
- Book ID
- 119944017
- Publisher
- BMJ Publishing Group
- Year
- 2013
- Tongue
- English
- Weight
- 629 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0040-6376
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Chest physiotherapy (CPT) is recommended for the clearance of bronchial secretions in the management of patients with cystic fibrosis (CF). The Flutterยฎ valve (Scandipharm, Birmingham, AL) has been introduced as an alternative method to CPT for airway mucus clearance. The objective of this study was